Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Severe Myofascial Pelvic Pain
NCT02173405Phase 1Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Aug 2014
- Primary completion
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in myofascial pelvic pain syndrome (MPPS) (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Visual Analog Scale (VAS) Pain Score at 1 month. Started Aug 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pelvic pain syndrome (MPPS)
Beyond the preview
Go deeper on NCT02173405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173405.